Related Experiment Videos
Efficacy of screening for gestational diabetes
American Journal of Perinatology
|January 1, 1985
Summary
Screening pregnant individuals for gestational diabetes mellitus (GDM) by age 24 is more cost-effective than universal screening, maintaining high sensitivity. Other risk factors for GDM are less efficient for screening.
Area of Science:
- Obstetrics and Gynecology
- Endocrinology
- Health Economics
Background:
- Gestational diabetes mellitus (GDM) affects maternal and fetal health.
- Effective screening strategies are crucial for early detection and management.
- Current screening methods involve universal or risk-factor-based approaches.
Purpose of the Study:
- To perform a cost analysis of glucose screening for gestational diabetes.
- To evaluate the effectiveness of universal versus risk-factor-based screening.
- To identify optimal screening strategies for GDM.
Main Methods:
- Prospective study of 434 pregnant patients undergoing glucose screening.
- Standard 50-gm oral glucose load and 1-hour plasma glucose test at 28 weeks.
- Oral glucose tolerance test for elevated screen tests (≥130 mg/dl).
- Documentation of clinical risk factors for diabetes.
Main Results:
- A 3.3% prevalence of GDM was found in patients with risk factors versus 2.4% without (not significant).
- Screening only patients aged 24 or older identified 83% of GDM cases.
- Age-based screening (≥24 years) was found to be more cost-effective than universal screening.
Conclusions:
- Screening for GDM based on risk factors other than age is inefficient.
- Screening only patients aged 24 years or older offers a more cost-effective approach than universal screening.
- Reduced sensitivity must be considered when adopting age-based GDM screening.